24 Hrs
المصدر:
The Washington Post
The Washington Post
جاهز للتشغيل
جاهز للتشغيل
Novo Nordisk has introduced a new weekly medication for Type 2 diabetes, offering increased convenience and reduced injection frequency. However, there are potential risks of hypoglycemia associated with the treatment.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading